vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and BANCFIRST CORP (BANF). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $181.0M, roughly 2.0× BANCFIRST CORP). BANCFIRST CORP runs the higher net margin — 32.9% vs -0.8%, a 33.6% gap on every dollar of revenue. On growth, BANCFIRST CORP posted the faster year-over-year revenue change (11.1% vs 9.4%). BANCFIRST CORP produced more free cash flow last quarter ($237.0M vs $36.1M). Over the past eight quarters, BANCFIRST CORP's revenue compounded faster (9.5% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
BancFirst Corporation is an Oklahoma-based financial services holding company. The company operates three subsidiary banks, BancFirst, an Oklahoma state-chartered bank; and Pegasus Bank and Worthington Bank, both Texas state-chartered banks.
ASIX vs BANF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $181.0M |
| Net Profit | $-2.8M | $59.5M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 41.6% |
| Net Margin | -0.8% | 32.9% |
| Revenue YoY | 9.4% | 11.1% |
| Net Profit YoY | -892.9% | 5.3% |
| EPS (diluted) | $-0.11 | $1.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $181.0M | ||
| Q3 25 | $374.5M | $175.5M | ||
| Q2 25 | $410.0M | $169.3M | ||
| Q1 25 | $377.8M | $164.8M | ||
| Q4 24 | $329.1M | $162.9M | ||
| Q3 24 | $398.2M | $163.7M | ||
| Q2 24 | $453.5M | $153.8M | ||
| Q1 24 | $336.8M | $151.0M |
| Q4 25 | $-2.8M | $59.5M | ||
| Q3 25 | $-2.6M | $62.7M | ||
| Q2 25 | $31.4M | $62.3M | ||
| Q1 25 | $23.3M | $56.1M | ||
| Q4 24 | $352.0K | $56.5M | ||
| Q3 24 | $22.3M | $58.9M | ||
| Q2 24 | $38.9M | $50.6M | ||
| Q1 24 | $-17.4M | $50.3M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 41.6% | ||
| Q3 25 | -0.9% | 45.0% | ||
| Q2 25 | 7.7% | 47.1% | ||
| Q1 25 | 7.7% | 43.1% | ||
| Q4 24 | -3.9% | 44.2% | ||
| Q3 24 | 7.5% | 45.2% | ||
| Q2 24 | 11.5% | 42.4% | ||
| Q1 24 | -7.0% | 42.5% |
| Q4 25 | -0.8% | 32.9% | ||
| Q3 25 | -0.7% | 35.7% | ||
| Q2 25 | 7.7% | 36.8% | ||
| Q1 25 | 6.2% | 34.0% | ||
| Q4 24 | 0.1% | 34.7% | ||
| Q3 24 | 5.6% | 36.0% | ||
| Q2 24 | 8.6% | 32.9% | ||
| Q1 24 | -5.2% | 33.3% |
| Q4 25 | $-0.11 | $1.75 | ||
| Q3 25 | $-0.10 | $1.85 | ||
| Q2 25 | $1.15 | $1.85 | ||
| Q1 25 | $0.86 | $1.66 | ||
| Q4 24 | $0.02 | $1.68 | ||
| Q3 24 | $0.82 | $1.75 | ||
| Q2 24 | $1.43 | $1.51 | ||
| Q1 24 | $-0.65 | $1.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.9B |
| Total Assets | $1.7B | $14.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $18.4M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $20.6M | — |
| Q4 25 | $815.2M | $1.9B | ||
| Q3 25 | $818.2M | $1.8B | ||
| Q2 25 | $823.7M | $1.7B | ||
| Q1 25 | $794.4M | $1.7B | ||
| Q4 24 | $774.6M | $1.6B | ||
| Q3 24 | $766.4M | $1.6B | ||
| Q2 24 | $746.6M | $1.5B | ||
| Q1 24 | $713.2M | $1.5B |
| Q4 25 | $1.7B | $14.8B | ||
| Q3 25 | $1.7B | $14.2B | ||
| Q2 25 | $1.6B | $14.0B | ||
| Q1 25 | $1.6B | $14.0B | ||
| Q4 24 | $1.6B | $13.6B | ||
| Q3 24 | $1.5B | $13.3B | ||
| Q2 24 | $1.5B | $12.7B | ||
| Q1 24 | $1.5B | $12.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $285.3M |
| Free Cash FlowOCF − Capex | $36.1M | $237.0M |
| FCF MarginFCF / Revenue | 10.0% | 130.9% |
| Capex IntensityCapex / Revenue | 7.7% | 26.7% |
| Cash ConversionOCF / Net Profit | — | 4.79× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $430.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $285.3M | ||
| Q3 25 | $26.6M | $75.4M | ||
| Q2 25 | $21.1M | $78.1M | ||
| Q1 25 | $11.4M | $77.0M | ||
| Q4 24 | $64.2M | $261.2M | ||
| Q3 24 | $57.3M | $77.6M | ||
| Q2 24 | $50.2M | $100.2M | ||
| Q1 24 | $-36.2M | $66.3M |
| Q4 25 | $36.1M | $237.0M | ||
| Q3 25 | $66.0K | $63.7M | ||
| Q2 25 | $-7.2M | $64.4M | ||
| Q1 25 | $-22.6M | $65.6M | ||
| Q4 24 | $29.8M | $224.5M | ||
| Q3 24 | $26.8M | $72.4M | ||
| Q2 24 | $16.7M | $94.1M | ||
| Q1 24 | $-71.6M | $56.1M |
| Q4 25 | 10.0% | 130.9% | ||
| Q3 25 | 0.0% | 36.3% | ||
| Q2 25 | -1.7% | 38.0% | ||
| Q1 25 | -6.0% | 39.8% | ||
| Q4 24 | 9.1% | 137.8% | ||
| Q3 24 | 6.7% | 44.2% | ||
| Q2 24 | 3.7% | 61.2% | ||
| Q1 24 | -21.3% | 37.1% |
| Q4 25 | 7.7% | 26.7% | ||
| Q3 25 | 7.1% | 6.7% | ||
| Q2 25 | 6.9% | 8.1% | ||
| Q1 25 | 9.0% | 6.9% | ||
| Q4 24 | 10.4% | 22.5% | ||
| Q3 24 | 7.7% | 3.2% | ||
| Q2 24 | 7.4% | 3.9% | ||
| Q1 24 | 10.5% | 6.8% |
| Q4 25 | — | 4.79× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | 0.67× | 1.25× | ||
| Q1 25 | 0.49× | 1.37× | ||
| Q4 24 | 182.29× | 4.62× | ||
| Q3 24 | 2.57× | 1.32× | ||
| Q2 24 | 1.29× | 1.98× | ||
| Q1 24 | — | 1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
BANF
Segment breakdown not available.
